ask="N/A"
ask_size="N/A"
average_daily_volume="587350"
bid="0.01"
bid_size="100"
book_value="11.38"
change="-0.31"
change_from_200_day_moving_average="0.43"
change_from_50_day_moving_average="-3.96"
change_from_52_week_high="-18.38"
change_From_52_week_low="21.87"
change_in_percent="-0.45%"
close="68.39"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.88"
ebitda="-230.87M"
eps_estimate_current_year="-6.14"
eps_estimate_next_quarter="-1.68"
eps_estimate_next_year="-6.72"
ex_dividend_date="N/A"
float_shares="37661000"
high="69.14"
high_52_weeks="86.77"
last_trade_date="1/23/2017"
last_trade_price="68.39"
last_trade_size="23952"
last_trade_time="4:00pm"
low="67.23"
low_52_weeks="46.52"
market_capitalization="2.79B"
moving_average_200_day="67.96"
moving_average_50_day="72.35"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="92.73"
open="68.65"
pe_ratio="N/A"
peg_ratio="-0.38"
percent_change_from_200_day_moving_average="+0.64%"
percent_change_from_50_day_moving_average="-5.47%"
percent_change_from_52_week_high="-21.18%"
percent_change_from_52_week_low="+47.01%"
previous_close="68.70"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.04"
price_per_sales="21929.79"
revenue="128000.00"
shares_outstanding="40859000"
short_ratio="10.26"
stock_exchange="NMS"
symbol="RARE"
volume="350990"
weeks_range_52="46.52 - 86.77"
